PMS2 expression decrease causes severe problems in mismatch repair

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• Lynch syndrome (LS) is the most common hereditary cancer syndrome.
• PMS2 is a susceptibility gene for LS, but its role is less understood than MLH1, MSH2, and MSH6.
• Previous studies show reduced expression of other LS genes impairs DNA repair.

Purpose of the Study:

• To investigate the impact of reduced PMS2 expression on DNA mismatch repair (MMR) efficiency.
• To determine if decreased PMS2 levels in cells correlate with MMR malfunction.

Main Methods:

• Utilized PMS2 knockdown cell models with varying residual PMS2 expression levels (19%, 33%, 53%).
• Assessed DNA mismatch repair efficiency in these modified cells.

Main Results:

• All tested levels of PMS2 knockdown significantly reduced MMR efficiency.
• Cells with PMS2 expression levels similar to those in LS mutation carriers exhibited the lowest repair efficiency.

Conclusions:

• Decreased PMS2 expression demonstrably impairs DNA mismatch repair capability.
• PMS2 is a critical gene for maintaining MMR function, even at moderate expression levels, impacting Lynch syndrome risk assessment.